Intra-Cellular Therapies to Host Third Quarter 2020 Financial Results Conference Call and Webcast

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) announced a conference call scheduled for November 9, 2020, at 8:30 a.m. ET to discuss financial results for Q3 2020 and provide a corporate update. Investors can join the call by dialing 1-(844) 835-6563 (international: 1-(970) 315-3916) using conference ID 1859956. The call will also be available via a webcast on their website's Investor Relations section. Intra-Cellular Therapies focuses on developing treatments for central nervous system disorders based on Nobel Prize-winning research.

NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Monday, November 9, 2020, to provide a corporate update and discuss details of the Company's financial results for the quarter ended September 30, 2020.

To access the live conference call via phone, dial 1-(844) 835-6563. The international dial-in number is 1-(970) 315-3916. The conference ID number for the live call is 1859956.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

CONTACT:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
jgrimaldi@burnsmc.com
212-213-0006

FAQ

When is the next conference call for Intra-Cellular Therapies (ITCI)?

The next conference call for Intra-Cellular Therapies is scheduled for November 9, 2020, at 8:30 a.m. ET.

How can I access the live webcast for Intra-Cellular Therapies' conference call?

The live webcast can be accessed through the Investor Relations section of Intra-Cellular Therapies' website.

What financial results will Intra-Cellular Therapies discuss in the upcoming call?

Intra-Cellular Therapies will discuss their financial results for the quarter ended September 30, 2020.

What is the purpose of the conference call on November 9, 2020?

The purpose of the conference call is to provide a corporate update and discuss financial results.